Eligibility of real-world patients with metastatic breast cancer for clinical trials
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference31 articles.
1. Evidence based medicine – New approaches and challenges;Masic;Acta Inf Med,2008
2. Recent advances in the management of lung cancer;Jones;Clin Med,2018
3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008
4. Re-evaluating eligibility criteria for oncology clinical trials: analysis of investigational New drug applications in 2015;Jin;J Clin Oncol,2017
5. The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies;Statler;Leukemia,2017
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer;Geburtshilfe und Frauenheilkunde;2024-09
2. Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis;Cancers;2024-05-08
3. Value of next generation sequencing (NGS) testing in advanced cancer patients;Journal of Medical Economics;2024-04-02
4. Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older;Frontiers in Oncology;2023-09-28
5. Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study;The Breast;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3